[1]
Laquer, V., Bruce, S., Schlesinger, T., Zeitouni, N., Torres, A., Cohen, J., Tu, J., Hanke, W., Goldman, M., Ozog, D., Markowitz, O., Gold, M., Nestor, M., Berman, B., Munavalli, G. and Pariser, D. 2019. A randomized, double blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA and narrowband red light in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT). SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S48. DOI:https://doi.org/10.25251/skin.3.supp.48.